Literature DB >> 35167411

OPTN (optineurin)-mediated selective autophagy prevents neurodegeneration due to herpesvirus infection.

Chandrashekhar D Patil1, Deepak Shukla1,2.   

Abstract

Very little is known about the mechanisms that restrict neurotropic herpesviruses such as herpes simplex virus-1 (HSV-1) from infecting the central nervous system (CNS) and causing widespread death of neurons. Likewise, HSV-1 is thought to play a role in chronic neurodegeneration, yet a direct association has remained elusive. To address these issues, we recently showed that the selective macroautophagy/autophagy receptor OPTN (optineurin) specifically targets HSV-1 proteins VP16 and gB for degradation to prevent viral spread in the brain. OPTN deficiency alters host cytokine expression and tissue-specific immune signaling, and enhances necroptotic death of infected neurons. HSV-1-infected optn knockout mice show higher susceptibility to lethal CNS infection and the surviving animals demonstrate cognitive deficiency. Our research suggests that OPTN-mediated autophagy provides an intrinsic immune barrier against neurotropic viruses and protects the CNS from neurodegenerative stress.

Entities:  

Keywords:  HSV-1; Herpesvirus; necroptosis; neurodegeneration; neuroprotection; optineurin; selective autophagy

Mesh:

Substances:

Year:  2022        PMID: 35167411      PMCID: PMC9037458          DOI: 10.1080/15548627.2022.2037223

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  1 in total

1.  OPTN is a host intrinsic restriction factor against neuroinvasive HSV-1 infection.

Authors:  Joshua Ames; Tejabhiram Yadavalli; Rahul Suryawanshi; James Hopkins; Alexander Agelidis; Chandrashekhar Patil; Brian Fredericks; Henry Tseng; Tibor Valyi-Nagy; Deepak Shukla
Journal:  Nat Commun       Date:  2021-09-13       Impact factor: 14.919

  1 in total
  1 in total

Review 1.  Optineurin in ocular herpes infection.

Authors:  Earon Grinage; Deepak Shukla
Journal:  Exp Eye Res       Date:  2022-04-04       Impact factor: 3.770

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.